ProPhase Labs, Inc. Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

The following table summarizes stock option activity during the three months ended March 31, 2026, (in thousands, except per share data).

Schedule of Stock Options Activity

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Total Intrinsic Value
Outstanding as of January 1, 2026		478	$	48.60		4.6	$	-
Granted		-		-
Forfeited/exprired		-		-
Outstanding as of March 31, 2026		478	$	48.60		4.3	$	-
Options vested and exercisable		340	$	53.72		3.9	$	-

The following table summarizes warrant activity during the three months ended March 31, 2026 (in thousands, except per share data):

Schedule of Warrant Activity

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)
Outstanding as of January 1, 2026		757	$	9.58		4.4
Granted		240		-		5.3
Outstanding as of March 31, 2026		997		7.27		4.4
Warrants vested and exercisable		997	$	7.27		4.4